The Valley Desk

NCT06351371 · Interventional trial

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

Overall registry status Active not recruiting

Phase 2

Conditions Malignant Solid Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov